Journal of the American Chemical Society
Communication
redox manipulation or protecting group interchange.31 Access
to 1−4 (a−d) in pure form will facilitate biological evaluation
of these molecules. Efforts are currently underway to divert the
inherent topological preferences of dimerization toward the
thiobinupharidine series of dimers.
review, see: Nicolaou, K. C.; Montagnon, T.; Snyder, S. A. Chem.
Commun. 2003, 551.
(14) Beckman rearrangement in the synthesis of a related piperidine:
LaLonde, R. T.; Muhammad, N.; Wong, C. F. J. Org. Chem. 1977, 42,
2113.
(15) See: Yoon, J.; Buchwald, S. L. Org. Lett. 2001, 3, 1129 and
references therein..
(16) Degrado, S. J.; Mizutani, H.; Hoveyda, A. H. J. Am. Chem. Soc.
2001, 123, 755.
(17) Jarugumilli, G. K.; Cook, S. P. Org. Lett. 2011, 8, 1904.
(18) Gou, S.; Yea, Z.; Shib, L.; Qinga, D.; Zhanga, W.; Wang, Y. Appl.
Organometal. Chem. 2010, 24, 517.
(19) Jarugumilli, G. K.; Zhu, C.; Cook, S. P. Eur. J. Org. Chem. 2012,
1712.
(20) Chae, J.; Yun, J.; Buchwald, S. L. Org. Lett. 2004, 6, 4809.
(21) Dowling, M. S.; Vanderwal, C. D. J. Am. Chem. Soc. 2010, 75,
6908.
(22) Use of 10 equiv of DIBAL-H as in ref. 8 led to incomplete
reduction and difficult purification.
(23) LaLonde, R. T.; Auer, E.; Wong, C. F.; Muralidharan, V. P. J.
Am. Chem. Soc. 1971, 93, 2501.
(24) Del Mazza, D.; Reinecke, M. G. J. Org. Chem. 1981, 46, 128.
(25) LaLonde, R. T.; Florence, R. A.; Horenstein, B. A.; Fritz, R. C.;
Silveira, L.; Clardy, J.; Krishnan, B. S. J. Org. Chem. 1985, 50, 85.
ASSOCIATED CONTENT
* Supporting Information
Experimental procedures and spectroscopic data for all new
compounds. This material is available free of charge via the
■
S
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by an ADI grant from TSRI and a
very generous donation of equipment and supplies from
Exelixis. We thank Dr. Guojun Pan for a sample of racemic 9.
We thank the Yu lab for the use of their LCMS; the Blackmond
lab for use of their GC; the Fokin lab for use of their glovebox;
and Dr. Curtis Moore and Professor Arnold L. Rheingold for X-
ray crystallographic analysis. We especially thank Professors Avi
Golan-Goldhirsh and Jacob Gopas for a donation of N. lutea
extract.
1
(26) Determined by integration of the H NMR spectrum and LC
chromatogram before purification.
(27) Nomenclature for dimers 1−4 is nonuniform in the literature.
Compound 2d was previously designated thionuphlutine B, but we
have removed the ‘B’ since there is no unique compound
‘thionuphlutine A,’ a name that was incorrectly assigned to the
known compound thiobinupharidine (1d). Compound 4d had
therefore been given the less systematic name ‘thionuphlutine C’ in
ref. 28. The ‘neo’ prefix is more effective to differentiate series 1 from 3
and 2 from 4, and refers to the stereochemistry of the C7′ quaternary
carbon.
(28) Compound 4d was produced in trace amounts by thermolysis of
a sulfoxide derived from 3d followed by reduction, but its structure
was not unequivocally proven. See: LaLonde, R. T.; Wong, C. F. Can.
J. Chem. 1978, 56, 56.
REFERENCES
■
(1) (a) Achmatowicz, O.; Wrobel, J. T. Tetrahedron Lett. 1964, 5,
129. (b) Achmatowlcz, O.; Banaszek, H.; Splteller, G.; Wrobel, J. T.
Tetrahedron Lett. 1964, 5, 927. (c) Achmatowicz, O.; Bellen, Z.
Tetrahedron Lett. 1962, 24, 1121.
(2) Birnbaum, G. I. Tetrahedron Lett. 1965, 6, 4149.
(3) For a review, see: LaLonde, R. T.; Wong, C. Pure Appl. Chem.
(29) Deteremined by HPLC analysis of reaction aliquots.
(30) Bures, J.; Armstrong, A.; Blackmond, D. G. J. Am. Chem. Soc.
2012, 134, 6741.
1977, 49, 169.
(4) Matsuda, H.; Morikawa, T.; Oda, M.; Asao, Y.; Yoshikawa, M.
Bioorg. Med. Chem. Lett. 2003, 13, 4445.
(31) Gaich, T.; Baran, P. S. J. Org. Chem. 2010, 75, 4657.
(5) Matsuda, H.; Yoshida, K.; Miyagawa, K.; Nemoto, Y.; Asao, Y.;
Yoshikawa, M. Bioorg. Med. Chem. Lett. 2006, 16, 1567.
(6) Ozer, J.; Eisner, N.; Ostrozhenkova, E.; Bacher, A.; Eisenreich,
W.; Benharroch, D.; Golan-Goldhirsh, A.; Gopas, J. Cancer Biol. Ther.
2009, 8, 1860.
(7) Wong, C. F.; LaLonde, R. T. Experientia 1975, 31, 15.
(8) Goodenough, K. M.; Moran, W. J.; Raubo, P.; Harrity, J. P. A. J.
Org. Chem. 2005, 70, 207.
(9) Lalonde, R. T.; Wong, C. F.; Das, K. C. J. Am. Chem. Soc. 1973,
95, 6342.
(10) LaLonde, R. T.; Eckert, T. S. Can. J. Chem. 1981, 59, 2298.
(11) Yoshikawa, M.; Murakami, T.; Wakao, S.; Ishikado, A.;
Murakami, N.; Yamahara, J.; Matsuda, H. Heterocycles 1997, 45, 1815.
(12) For chiral pool syntheses, see: (a) Katoh, M.; Mizutani, H.;
Honda, T. Tetrahedron Lett. 2005, 46, 5161. (b) Katoh, M.; Mizutani,
H.; Honda, T. Heterocycles 2006, 69, 193. (c) Ref. 8; (d) Moran, W. J.;
Goodenough, K. M.; Raubo, P.; Harrity, J. P. A. Org. Lett. 2003, 5,
3427. (e) Fowler, F. W.; Hwang, Y. C. J. Org. Chem. 1985, 50, 2719.
(13) For recent examples of spontaneous dimerizations to complex
secondary metabolites, see: (a) Nicolaou, K. C.; Vassilikogiannakis, G.;
Simonsen, K. B.; Baran, P. B.; Zhong, Y.-L.; Vidali, V. P.; Pitsinos, E.
N.; Couladouros, E. A. J. Am. Chem. Soc. 2000, 122, 3071. (b) Li, C.;
Lobkovsky, E.; Porco, J. A., Jr. J. Am. Chem. Soc. 2000, 122, 10484.
(c) Herzon, S. B.; Myers, A. G. J. Am. Chem. Soc. 2005, 127, 5342.
(d) Baran, P. S.; Hafensteiner, B. D.; Ambhaikar, N. B.; Guerrero, C.
A.; Gallagher, J. D. J. Am. Chem. Soc. 2006, 128, 8678. (e) For a
D
dx.doi.org/10.1021/ja310778t | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX